Search
for
Sort by
Research 31–60 of 1000+
- Holistic homeopathic management of grade IV female pattern baldness with genetic predisposition: A 27-month follow-up case from Dr. Batra’s® homeopathy clinic
- Restoration of hair growth in grade IV female androgenetic alopecia at Dr. Batra’s® using individualized homeopathy: A case report
- 走进非洲传统医药学宝库IV：与良性前列腺肥大、农民利益、品种灭绝、国际法规和巨大经济效益休戚相关的非洲李
- A Clinical Study of Androgenetic Alopecia(IV)
- Used Right, IV Arsenic Is Safe & Effective
- Immunofluorescent localization of collagen types I, III and IV, fibronectin, laminin, and basement membrane proteoglycan in developing mouse skin
- Design of an artificial skin. IV. Use of island graft to isolate organ regeneration from scar synthesis and other processes leading to skin wound closure
- Forensic chemical study on human hair. IV. Identification of brand of hair sprays and hair growth promoters by components remaining on human hair, and example of forensic hair examination.
- Short histological kaleidoscope – recent findings in histology. Part IV
- Association between postoperative nadir hematocrit and mortality within 28-day after coronary artery bypass grafting: A retrospective cohort study based on the MIMIC-IV database
- Immortalized Rat Whisker Dermal Papilla Cells Cooperate with Mouse Immature Hair Follicle Buds to Activate Type IV Procollagenases in Collagen Matrix Coculture: Correlation with Ability to Promote Hair Follicle Development in Nude Mouse Grafts
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial
- Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV)
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- An open label, multi-center clinical trial of topical 5% minoxidil solution for the treatment of male androgenetic alopecia (a phase IV study)
- <i>J. Cosmet. Sci., </i>58, 629–636 (November/December 2007) Hair breakage during combing. IV. Brushing and combing hair
- Effectiveness of Topical Minoxidil (5%) Plus Topical Finasteride (0.1%) Fixed-Dose Combination Versus Topical Minoxidil (5%) Plus Oral Finasteride (1 Mg/Day) in Grade II-IV Androgenetic Alopecia: A Randomized, Double Blind Clinical Trial
- Serenoa repens (Saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part I
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Pulse Corticosteroid Therapy for Alopecia Areata in Children: A Retrospective Study
- Zinc deficiency during total parenteral nutrition in childhood
- Minoxidil overdose with ecg changes: Case report and review
- Chronological clinicopathological characterization of rapidly progressive alopecia areata resistant to multiple i.v. corticosteroid pulse therapies: An implication for improving the efficacy
- Group A Streptococcal Sepsis and Arthritis
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- Predominance of CD27-PD-1- Effector Memory T Cells Re-Expressing CD45RA Characterizes Treatment-Resistant Severe Alopecia Areata
- Overnight loss of pigmented hair in autoimmune autonomic neuropathy treated with IVIg
- Acute Kidney Injury following Ingestion of Topical Minoxidil